Cargando…
Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma.
It has been suggested that angiogenesis and angiogenic factors may be strong predictors of relapse in patients with breast carcinoma. We measured the levels of the angiogenic peptide basic fibroblast growth factor (bFGF) in 140 breast tumour cytosols using an immunoassay. There were no significant d...
Autores principales: | Colomer, R., Aparicio, J., Montero, S., Guzmán, C., Larrodera, L., Cortés-Funes, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228128/ https://www.ncbi.nlm.nih.gov/pubmed/9365172 |
Ejemplares similares
-
A Heparin-Mimicking Polymer Conjugate Stabilizes Basic Fibroblast Growth Factor (bFGF)
por: Nguyen, Thi H., et al.
Publicado: (2013) -
Stimulation of wound healing using bioinspired hydrogels with basic fibroblast growth factor (bFGF)
por: Zhang, Xiaoyu, et al.
Publicado: (2018) -
Immunohistochemical expression of CD34 and basic fibroblast growth factor (bFGF) in oral submucous fibrosis
por: Pandiar, Deepak, et al.
Publicado: (2014) -
Sustained Release of Basic Fibroblast Growth Factor (bFGF) Encapsulated Polycaprolactone (PCL) Microspheres Promote Angiogenesis In Vivo
por: Arunkumar, Pala, et al.
Publicado: (2019) -
Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis
por: Hu, Mingming, et al.
Publicado: (2016)